Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Real-life Study of the Use of Cabotegravir Plus Rilpivirine Long-acting in ART-experienced Pre-treated People With HIV

NCT06518408 is registered in ClinicalTrials.gov with University Hospital Virgen de las Nieves as lead sponsor.

NCT NCT06518408
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06518408 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Real-life Study of the Use of Cabotegravir Plus Rilpivirine Long-acting in ART-experienced Pre-treated People With HIV
Lead sponsor
University Hospital Virgen de las Nieves
Phase
Observational
Overall status
Active, not recruiting
Start date
June 1, 2023
Completion date
September 30, 2027
Enrollment
287 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

human immunodeficiency virus